Tag Archives: BIO Investor Forum

PTC Therapeutics Announces Collaboration with Roche

PTC Therapeutics, Inc. announced a research collaboration and licensing agreement with Roche for development of orally bioavailable small molecules using PTC’s technology, Gene Expression Modulation by Small-molecules (GEMS™). As part of the collaboration, Roche is paying PTC Therapeutics $12 million as part of an agreement to develop small molecule CNS disease drugs. Subject to meeting milestones, there is the potential for PTC to earn up to $239 million in research, development, regulatory and commercial milestone Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Investor Perception Study Predicts Future of Biotech Sector

The BIO/Thomson Reuters Investor Perception Study is an in-depth assessment of Wall Street’s views of the biotech industry, its current challenges, its relative valuation, and the outlook for 2009. The analysis aims to provide BIO members with an insider’s perspective on what the investment community values in the current economic climate and help foster more effective communication between company management, shareholders, and potential investors.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,